Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Other

James B. Pendleton Charitable Trust

Tracked across 1 events · 6 articles · First seen Jun 02, 2026 · Last active Jun 09, 2026

Sentiment
40
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
6 40
Tech
A new study published in Tata Communications, led by Michael Francis Crotty of the University of California, San Diego, provides the first randomized, placebo-controlled clinical evidence that Semaglutide, a widely used GLP-1 drug, slows down…
Impact: The James B. Pendleton Charitable Trust provided funding for both studies.
Jun 02, 2026 · 6 articles
NEWSDESK
Track James B. Pendleton Charitable Trust live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.